Lorbrexen(劳拉替尼),通用的Lorbrena是处方药用来治疗转移性非小细胞肺癌患者中有一定类型的异常间变性淋巴瘤激酶(ALK)基因.劳拉替尼用于已经接受的患者alectinib,ceritinib或两者crizotinib和至少1种其他药物治疗NSCLC那是造成通过这ALK基因.Lorbrexen已制成的由孟加拉珠峰制药在孟加拉.

必须采取口服地每天1次有或無食物.

2 客户评论

---

Alba ca*****@*****il.com , *****904 In my country (Colombia), you cannot get some drugs for cancer, even though they are approved by entities such as FDA and EMEA, our authorities have not given approval; I have non-small cell lung cancer, and I receive treatment with Lorlatinib, but I have had to travel outside the country to buy the first doses of the original outside the country at a very high price, a few weeks ago I discovered that the drug has a generic that It is made in Bangladesh and I also found this wonderful service. So I managed to get the first bottle of this medicine, sent through "Medicine for world". I am very grateful for your service.

Derbieh Wa*****@*****il.com , *****856 If I can give more than 5 stars I would do that. They are so kind and friendly. The shipment of the medicine was fast. They reply on time. Keep it up and wish you the best.